---
document_datetime: 2025-06-18 11:21:47
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/anzupgo-epar-all-authorised-presentations_en.pdf
document_name: anzupgo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6986785
conversion_datetime: 2025-12-14 22:25:18.168577
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number                                     | (Invented) name         | Strength                | Pharmaceutical Form   | Route of Administration                   | Immediate Packaging                             | Content (concentration)   | Pack size                                               |
|----------------------------------------------------|-------------------------|-------------------------|-----------------------|-------------------------------------------|-------------------------------------------------|---------------------------|---------------------------------------------------------|
| EU/1/24/1851/001 EU/1/24/1851/002 EU/1/24/1851/003 | Anzupgo Anzupgo Anzupgo | 20 mg/g 20 mg/g 20 mg/g | Cream Cream Cream     | Cutaneous use Cutaneous use Cutaneous use | tube (laminate) tube (laminate) tube (laminate) | 15 g 60 g 15 g + 60 g     | 1 tube 1 tube 3 (2 x 15 g + 1 x 60 g) tubes (multipack) |